Has Mitotane Been Launched in China? Let's Find Out

Many patients with adrenocortical carcinoma are closely following a key question: Has mitotane been launched in China? Mitotane is a drug used to treat adrenocortical carcinoma, adrenocortical hyperplasia, and Cushing's syndrome, and its launch in China has attracted much attention.

I. Efficacy and Uses of Mitotane

Mitotane is an adrenocorticolytic drug, mainly used to treat adrenal-related diseases, including adrenocortical carcinoma, adrenocortical hyperplasia, and Cushing's syndrome. Its mechanism of action is to destroy the endoplasmic reticulum in adrenocortical cells and inhibit the synthesis of cortisol, thereby achieving a therapeutic effect.

II. Application of Mitotane Abroad

In some countries, mitotane has been included in the standard treatment protocols for adrenocortical carcinoma and is widely used in clinical practice. It has shown good therapeutic effects in the treatment of certain tumors and diseases, providing more treatment options for patients. For example, in the United States, the use of mitotane has a long history, and it has played an important role in the treatment of adrenocortical carcinoma.

III. Launch of Mitotane in China

According to the latest information, mitotane was officially approved for launch in China by the National Medical Products Administration (NMPA) on September 8, 2023. On January 7, 2025, mitotane was officially launched and sold in mainland China. This marks that patients with adrenocortical carcinoma in China can finally obtain this important drug through legal channels.

IV. Future Outlook

The launch of mitotane in China has brought new hope to patients with adrenocortical carcinoma. With the advancement of more research and clinical applications, mitotane is expected to further improve patients' survival rates and quality of life. In addition, relevant enterprises are also working hard to promote the inclusion of mitotane in medical insurance to reduce the economic burden on patients.

If needed, you can consult the customer service of Dingxiang International, which is stationed in India and offers direct mail-order purchasing from India without involving any third parties, and has been affirmed by many patients in the domestic field.